Uric Acid and Menopausal Age in Acute Kidney Injury

Asan Medical Center

Status: Completed

Conditions: Uric Acid

Treatments: Other: No Intervention: Observational Cohort

Study type: Observational

Funder types: Other

Identifiers

NCT07044934

AMC [2024-1090]

Details and patient eligibility

About

Preoperative serum uric acid significantly impacted acute kidney injury in female patients undergoing non-cardiac surgery, with differential effects observed before and after menopause.

Full description

Preoperative serum uric acid has been increasingly recognized as a potential biomarker associated with acute kidney injury in various clinical settings. However, the sex-specific and hormonal influences on this association remain unclear, particularly in the context of non-cardiac surgery. Female patients, who experience significant physiological changes across the menopausal transition, may exhibit different renal susceptibilities to elevated serum uric acid levels.

In this retrospective cohort study, the investigators aimed to evaluate the association between preoperative serum uric acid levels and postoperative acute kidney injury in female patients undergoing non-cardiac surgery, with a particular focus on menopausal status. Women were stratified into premenopausal and postmenopausal groups based on age and clinical criteria. The investigators hypothesized that the threshold and pattern of serum uric acid-associated acute kidney injury risk may differ between these two populations due to differences in hormonal status and baseline renal reserve.

Enrollment: 127,052 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female patients aged 18 years and older who underwent elective non-cardiac surgery

Exclusion criteria

• Patients with gout
• Patients who underwent nephrectomy or kidney transplantation (either as recipients or donors)
• Patients diagnosed with chronic kidney disease or who had already undergone kidney replacement therapy
• Patients with estimated glomerular filtration rate < 30 mL/min/1.73m²; and patients with incomplete data or missing laboratory values

Trial design

127,052 participants in 2 patient groups

Premenopausal Women

Treatment:

Other: No Intervention: Observational Cohort

Postmenopausal Women

Treatment:

Other: No Intervention: Observational Cohort